Entity/Public Space Stock Epinephrine
Stock epinephrine is rapidly moving beyond the school walls and out to public venues – from theme parks, restaurants and sports arenas to daycare centers and more.
Thirty states states have now passed what are called “entity laws” (as of Oct. 3, 2016), legislation that permits venues to maintain an epinephrine auto-injector, with the intention of reducing the time it takes to get lifesaving epinephrine to a person having a sudden anaphylactic reaction.
States colored yellow on the map below have entity legislation that has been introduced into the state legislature and referred to committee for consideration in the current or upcoming session.
States colored red are without entity legislation.
Click on the state listings below to read the legislation.
|Green states:||Yellow states:||Red states:|
For questions and to get involved in Entity Legislation in your state, contact Brenda Silvia-Torma, Project Manager, bsilvia-torma@AllergyAsthmaNetwork.org or 800.878.4403.